Discovery and characterization of a potent and selective EP4 receptor antagonist.
Bioorg Med Chem Lett
; 25(16): 3176-8, 2015 Aug 15.
Article
in En
| MEDLINE
| ID: mdl-26091726
ABSTRACT
EP4 is a prostaglandin E2 receptor that is a target for potential anti-nociceptive therapy. Described herein is a class of amphoteric EP4 antagonists which reverses PGE2-induced suppression of TNFα production in human whole blood. From this class, a potent and highly bioavailable compound (6) has been selected for potential clinical studies. EP4 binding and functional data, selectivity, and pharmacokinetic properties of this compound are included.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Prostaglandin E, EP4 Subtype
/
Analgesics
Limits:
Animals
/
Humans
Language:
En
Journal:
Bioorg Med Chem Lett
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2015
Document type:
Article